NCT00797576

Brief Summary

The purpose of this study is to compare Cardiac Magnetic Resonance (CMR) Imaging with transesophageal echocardiography (TEE) in detecting the presence of LAA thrombi in men and women with atrial fibrillation presenting for cardioversion.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2008

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 24, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 25, 2008

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
Last Updated

June 22, 2010

Status Verified

August 1, 2009

Enrollment Period

2 years

First QC Date

November 24, 2008

Last Update Submit

June 21, 2010

Conditions

Keywords

left atrial appendage thrombitransesophageal echocardiogramcardiac magnetic resonance imagingatrial fibrillationcardioversion

Outcome Measures

Primary Outcomes (1)

  • Accuracy values for CMR Imaging for detection of LAA thrombus. (sensitivity, specificity, negative predictive value, and positive predictive value)

    24 hours

Study Arms (2)

1/Cases

Subjects whom had cardioversion aborted due to LAA thrombus or suspicion of LAA thrombus on TEE.

2/Controls

Subjects with underlying atrial fibrillation undergoing elective TEE as clinically indicated for any reason.

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study cases will consist of subjects referred for TEE prior to cardioversion who are found to have LAA thrombus present. Control subjects will be patients referred for TEE with chronic atrial fibrillation that will not be undergoing cardioversion. All subjects will be patients from our facility, Gundersen Lutheran Health System, La Crosse, WI.

You may qualify if:

  • atrial fibrillation

You may not qualify if:

  • ICDs
  • pacemakers
  • intracranial clips
  • intracranial stimulator devices
  • insulin pumps
  • intra ocular metal foreign bodies
  • cochlear implants
  • LAA amputation as part of CABG and/or valve surgery
  • GFR \< 60 mL/min

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gundersen Lutheran Health System

La Crosse, Wisconsin, 54601, United States

RECRUITING

Related Publications (9)

  • Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol. 1969 Feb;23(2):208-16. doi: 10.1016/0002-9149(69)90068-x. No abstract available.

    PMID: 4180019BACKGROUND
  • Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz SB, Epstein SE. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation. 1976 Feb;53(2):273-9. doi: 10.1161/01.cir.53.2.273.

    PMID: 128423BACKGROUND
  • Stein B, Halperin JL, Fuster V. Should patients with atrial fibrillation be anticoagulated prior to and chronically following cardioversion? Cardiovasc Clin. 1990;21(1):231-47; discussion 248-9. No abstract available.

    PMID: 2199050BACKGROUND
  • Paydarfar D, Krieger D, Dib N, Blair RH, Pastore JO, Stetz JJ Jr, Symes JF. In vivo magnetic resonance imaging and surgical histopathology of intracardiac masses: distinct features of subacute thrombi. Cardiology. 2001;95(1):40-7. doi: 10.1159/000047342.

    PMID: 11385191BACKGROUND
  • Barkhausen J, Hunold P, Eggebrecht H, Schuler WO, Sabin GV, Erbel R, Debatin JF. Detection and characterization of intracardiac thrombi on MR imaging. AJR Am J Roentgenol. 2002 Dec;179(6):1539-44. doi: 10.2214/ajr.179.6.1791539.

    PMID: 12438051BACKGROUND
  • Ohyama H, Mizushige K, Hosomi N. Magnetic resonance imaging of left atrial thrombus. Heart. 2002 Sep;88(3):233. doi: 10.1136/heart.88.3.233. No abstract available.

    PMID: 12181211BACKGROUND
  • Ohyama H, Hosomi N, Takahashi T, Mizushige K, Osaka K, Kohno M, Koziol JA. Comparison of magnetic resonance imaging and transesophageal echocardiography in detection of thrombus in the left atrial appendage. Stroke. 2003 Oct;34(10):2436-9. doi: 10.1161/01.STR.0000090350.73614.0F. Epub 2003 Sep 11.

    PMID: 12970519BACKGROUND
  • Mohrs OK, Nowak B, Petersen SE, Welsner M, Rubel C, Magedanz A, Kauczor HU, Voigtlaender T. Thrombus detection in the left atrial appendage using contrast-enhanced MRI: a pilot study. AJR Am J Roentgenol. 2006 Jan;186(1):198-205. doi: 10.2214/AJR.04.1504.

    PMID: 16357402BACKGROUND
  • Saksena S, Sra JS, Jordaens L, et al. Intracardiac Echocardiography-Guided Cardioversion Helps Interventional Procedures (ICE-CHIP) trial. Heart Rhythm Society 2007 Scientific Sessions; May 11, 2007; Denver, CO. Late Breaking clinical Trials II.

    BACKGROUND

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Raju G Ailiani, MD

    Gundersen Lutheran Health System

    PRINCIPAL INVESTIGATOR
  • Vicki L McHugh, MS

    Gundersen Lutheran Medical Foundation

    STUDY DIRECTOR

Central Study Contacts

Raju G Ailiani, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 24, 2008

First Posted

November 25, 2008

Study Start

June 1, 2008

Primary Completion

June 1, 2010

Study Completion

July 1, 2010

Last Updated

June 22, 2010

Record last verified: 2009-08

Locations